1. Home
  2. AIP vs CTKB Comparison

AIP vs CTKB Comparison

Compare AIP & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arteris Inc.

AIP

Arteris Inc.

HOLD

Current Price

$14.50

Market Cap

767.5M

Sector

Technology

ML Signal

HOLD

Logo Cytek Biosciences Inc.

CTKB

Cytek Biosciences Inc.

HOLD

Current Price

$4.22

Market Cap

652.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIP
CTKB
Founded
2003
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
767.5M
652.1M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
AIP
CTKB
Price
$14.50
$4.22
Analyst Decision
Strong Buy
Hold
Analyst Count
3
5
Target Price
$16.83
$5.70
AVG Volume (30 Days)
492.5K
782.3K
Earning Date
01-01-0001
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
4.65
N/A
EPS
N/A
N/A
Revenue
$70,579,000.00
$193,015,000.00
Revenue This Year
$30.24
$5.02
Revenue Next Year
$19.50
$7.89
P/E Ratio
N/A
N/A
Revenue Growth
22.27
17.67
52 Week Low
$5.64
$2.37
52 Week High
$19.85
$6.18

Technical Indicators

Market Signals
Indicator
AIP
CTKB
Relative Strength Index (RSI) 41.79 33.16
Support Level $13.58 $4.00
Resistance Level $14.64 $4.26
Average True Range (ATR) 1.03 0.22
MACD 0.01 0.03
Stochastic Oscillator 21.02 23.00

Price Performance

Historical Comparison
AIP
CTKB

About AIP Arteris Inc.

Arteris Inc is a provider of semiconductor system IP, including interconnect and other intellectual property, (collectively, System IP) technology. Its IP technology manages the on-chip communications and IP block deployments in System-on-Chip (SoC) semiconductors and systems of chiplets. Its proprietary System IP solutions achieve this by connecting client IP blocks such as processors, memories, artificial intelligence/machine learning (AI/ML) accelerators, graphics subsystems, safety and security, and other input/output subsystems (I/Os) via multiple Network-on-Chips (NoCs). The company operates in Americas, Asia Pacific and Europe, Middle East, out of which it derives maximum profit from Asia Pacific.

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

Share on Social Networks: